O165 SIMEPREVIR PLUS SOFOSBUVIR WITH/WITHOUT RIBAVIRIN IN HCV GENOTYPE 1 PRIOR NULL-RESPONDER/TREATMENT-NAIVE PATIENTS (COSMOS STUDY): PRIMARY ENDPOINT (SVR12) RESULTS IN PATIENTS WITH METAVIR F3–4 (COHORT 2)

Authors:
  • ELE. Lawitz
    E. Lawitz
  • RGR. Ghalib
    R. Ghalib
  • MRM. Rodriguez-Torres
    M. Rodriguez-Torres
  • ZYZ.M. Younossi
    Z.M. Younossi
  • ACA. Corregidor
    A. Corregidor
  • MSM.S. Sulkowski
    M.S. Sulkowski
  • EDE. DeJesus
    E. DeJesus
  • BPB. Pearlman
    B. Pearlman
  • MRM. Rabinovitz
    M. Rabinovitz
  • NGN. Gitlin
    N. Gitlin
  • JLJ.K. Lim
    J.K. Lim

Abstract
No abstract available